Difference between revisions of "Template:Chromalveolate antiparasitics"
Jump to navigation
Jump to search
imported>Newone |
|||
| (27 intermediate revisions by 19 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Chromalveolate antiparasitics |
| − | | title = [[Antiparasitic]]s | + | | title = [[Antiparasitic]]s – [[antiprotozoal agent]]s – [[Chromalveolata]] antiparasitics ([[ATC code P01|P01]]) |
| + | | listclass = hlist | ||
| state = {{{state<includeonly>|autocollapse</includeonly>}}} | | state = {{{state<includeonly>|autocollapse</includeonly>}}} | ||
| − | |||
| − | |group1 | + | | group1 = [[Alveolate|Alveo-<br>late]] |
| − | |list1 | + | | list1 = |
| − | + | {{Navbox|subgroup | |
| − | | group1 =[[Apicomplexa|Apicom-< | + | | group1 = [[Apicomplexa|Apicom-<br>plexa]] |
| − | | list1 | + | | list1 = |
| − | + | {{Navbox|subgroup | |
| − | | group1 =[[Conoidasida]]/< | + | | group1 = [[Conoidasida]]/<br>([[Coccidiostat]]s) |
| − | | list1 | + | | list1 = |
| − | + | {{Navbox|subgroup | |
| − | | group1 =[[Cryptosporidiosis#Treatment|Cryptosporidiosis]] | + | | group1 = [[Cryptosporidiosis#Treatment|Cryptosporidiosis]] |
| − | | list1 = ''[[ | + | | list1 = |
| + | * ''[[thiazolide]]s'' ([[nitazoxanide]]) | ||
| − | | group2 =[[Isosporiasis#Treatment|Isosporiasis]] | + | | group2 = [[Isosporiasis#Treatment|Isosporiasis]] |
| − | | list2 | + | | list2 = |
| + | * [[trimethoprim/sulfamethoxazole]]<sup>#</sup> | ||
| − | | group3 =[[Toxoplasmosis#Treatment|Toxoplasmosis]] | + | | group3 = [[Toxoplasmosis#Treatment|Toxoplasmosis]] |
| − | | list3 | + | | list3 = |
| + | * [[pyrimethamine]] | ||
| + | * [[sulfadiazine]] | ||
| + | * [[clindamycin]] | ||
| + | * [[atovaquone]] | ||
| + | }} | ||
| − | + | | group2 = [[Aconoidasida]] | |
| − | + | | list2 = | |
| − | + | {{Navbox|subgroup | |
| − | | group2 =[[Aconoidasida]] | ||
| − | | list2 | ||
| − | |||
| − | | group1 =[[Antimalarial drug|Malaria]] | + | | group1 = [[Antimalarial drug|Malaria]] |
| − | | list1 | + | | list1 = |
| − | + | {{Navbox|subgroup | |
| − | | group1 =Individual < | + | | group1 = Individual <br>agents |
| − | | list1 | + | | list1 = |
| − | + | {{Navbox|subgroup | |
| − | | group1 =[[Hemozoin#Inhibitors|Hemozoin< | + | | group1 = [[Hemozoin#Inhibitors|Hemozoin<br>inhibitors]] |
| − | | list1 | + | | list1 = |
| − | + | {{Navbox|subgroup | |
| − | | group1 = [[Aminoquinoline]]s | + | | group1 = [[Aminoquinoline]]s |
| − | | list1 = (4-): [[ | + | | list1 = |
| + | * [[4-Aminoquinoline|(4-)]]: [[amodiaquine]]<sup>#</sup> | ||
| + | * [[chloroquine]]<sup>#</sup> | ||
| + | * [[hydroxychloroquine]]<sup>#</sup> | ||
| − | + | * [[8-Aminoquinoline|(8-)]]: [[primaquine]]<sup>#</sup> | |
| − | + | * [[pamaquine]]<sup>‡</sup> | |
| + | * [[tafenoquine]] | ||
| − | | | + | | group2 = 4-Methanolquinolines |
| − | | | + | | list2 = |
| + | * [[mefloquine]]<sup>#</sup> | ||
| + | * [[quinine]]<sup>#</sup> | ||
| + | * [[quinidine]] | ||
| + | | group3 = Other | ||
| + | | list3 = | ||
| + | * [[lumefantrine]] | ||
| + | ** [[artemether/lumefantrine|+ artemether]]<sup>#</sup> | ||
| − | }} | + | * [[halofantrine]] |
| + | }} | ||
| group2 = [[Antifolate]]s | | group2 = [[Antifolate]]s | ||
| − | | list2 | + | | list2 = |
| − | + | {{Navbox|subgroup | |
| − | | group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitors]] | + | | group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitors]] |
| − | | list1 = | + | | list1 = |
| + | * [[pyrimethamine]] | ||
| − | + | * ''[[biguanide]]s'' | |
| − | + | ** [[chlorproguanil]] | |
| + | ** [[proguanil]]<sup>#</sup> | ||
| − | | | + | | group2 = [[Sulfonamide (medicine)|Sulfonamides]] |
| − | | | + | | list2 = |
| + | * [[sulfadoxine]] | ||
| + | * [[sulfalene]] | ||
| − | }} | + | | group3 = Co-formulation |
| + | | list3 = | ||
| + | * [[sulfadoxine/pyrimethamine]] (SP)<sup>#</sup> | ||
| + | }} | ||
| − | | group3 = [[Sesquiterpene lactones|Sesquiterpene< | + | | group3 = [[Sesquiterpene lactones|Sesquiterpene<br>lactones]] |
| − | | list3 | + | | list3 = |
| + | * [[artemether]]<sup>#</sup> | ||
| + | * [[artemisinin]] | ||
| + | * [[artemotil]] | ||
| + | * [[artesunate]]<sup>#</sup> | ||
| + | * [[dihydroartemisinin]] | ||
| group4 = Other | | group4 = Other | ||
| − | | list4 | + | | list4 = |
| + | * [[atovaquone]] ([[Atovaquone/proguanil|+ proguanil]]) | ||
| + | * [[tetracycline]] | ||
| + | * [[doxycycline]]<sup>#</sup> | ||
| + | * [[clindamycin]] | ||
| + | * [[mepacrine]] | ||
| + | * [[pyronaridine]] | ||
| + | * [[piperaquine]] | ||
}} | }} | ||
| − | + | | group2 = Combi-<br>nations | |
| − | | group2 = Combi-< | + | | list2 = |
| − | | list2 | + | {{Navbox|subgroup |
| − | | | + | |
| + | | group1 = Fixed-dose (co-formulated) [[Artemisinin|ACTs]] | ||
| + | | list1 = | ||
| + | * [[artemether/lumefantrine]]<sup>#</sup> | ||
| + | * [[arterolane]]/piperaquine | ||
| + | * [[artesunate/amodiaquine]] (ASAQ) | ||
| + | * [[artesunate/mefloquine]] (ASMQ) | ||
| + | * [[artesunate/pyronaridine]] | ||
| + | * [[piperaquine/dihydroartemisinin]] | ||
| − | | | + | | group3 = Other combinations<br>(not co-formulated) |
| − | | | + | | list3 = |
| + | * artesunate/mefloquine | ||
| + | * artesunate/SP | ||
| + | * quinine/clindamycin | ||
| + | * quinine/doxycycline | ||
| + | * quinine/tetracycline | ||
| − | + | }} | |
| − | |||
| − | |||
| − | |||
| − | }} | ||
}} | }} | ||
| group2 = [[Babesiosis#Treatment|Babesiosis]] | | group2 = [[Babesiosis#Treatment|Babesiosis]] | ||
| − | | list2 | + | | list2 = |
| − | + | * [[clindamycin]] | |
}} | }} | ||
| − | |||
| − | |||
}} | }} | ||
| − | | group2 = [[Ciliophora|Cilio-< | + | | group2 = [[Ciliophora|Cilio-<br>phora]] |
| − | | list2 | + | | list2 = |
| + | * [[Balantidiasis#Treatment|Balantidiasis]]: [[tetracycline]] | ||
}} | }} | ||
| − | |group2 | + | | group2 = [[Heterokont|Hetero-<br>kont]] |
| − | |list2 | + | | list2 = |
| + | * [[Blastocystosis#Treatment|Blastocystosis]]: [[metronidazole]] | ||
| belowstyle = background: transparent; padding: 0px; | | belowstyle = background: transparent; padding: 0px; | ||
| − | | below = {{PharmNavFootnote | + | | below = {{PharmNavFootnote}} |
}}<noinclude> | }}<noinclude> | ||
| − | [[Category:Drug_templates by ATC | + | {{collapsible option}} |
| + | |||
| + | [[Category:Antiprotozoal agents]] | ||
| + | [[Category:Drug_templates by ATC]] | ||
| + | |||
</noinclude> | </noinclude> | ||
Latest revision as of 04:48, 1 August 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Chromalveolate antiparasitics|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Chromalveolate antiparasitics|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Chromalveolate antiparasitics|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.